← Evidence map

ArticleFrontiers in cell and developmental biology2021

LuHui Derivative, A Novel Compound That Inhibits the Fat Mass and Obesity-Associated (FTO), Alleviates the Inflammatory Response and Injury in Hyperlipidemia-Induced Cardiomyopathy.

Ying Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34881240